TBI — Stock Film
STOCK FILMSCENE 1/11TBI · $6.75
Stock Expert AI presents
TBI
TrueBlue, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
TrueBlue, Inc. A quick introduction.

On the stock market since 1994, it operates in the world of heavy industry. It has 3,500 employees. Now — the numbers.

on the stock market since 1994
3,500 employees
$205.2M market value
Revenue last year:
$0
The loss that same year:
$0
Sales don’t cover the costs; the gap drains from the cash pile every year.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

WHERE DOES THE MONEY COME FROM?
55%PeopleReady
PeopleReady 55%PeopleManagement 34%PeopleScout 12%
55% of all revenue comes from a single line: PeopleReady.

The biggest line carries real weight, but it doesn’t decide everything on its own.

THE SALES TREND
Sales have been shrinking.

An average decline of 7% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$2.2B
2021
$2.3B
2022
$1.9B
2023
$1.6B
2024
$1.6B
2025
In the vault right now:
$0
DEBT: $170.6M
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
26
very weak

Clearly below the class average.

FINANCIAL STRENGTH
51
average

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
16
very weak

Clearly below the class average.

GROWTH
41
weak

Clearly below the class average.

PRICE MOMENTUM
94
very strong

The stock has been running stronger than the market lately.

WORTH WATCHING

Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.

Business Quality: Profit power and business quality trail similar companies in the sector.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 79% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/1
Sales are holding up

The company sells $1.6B a year; the problem isn’t sales — it’s costs running above that number.

1
THE RISKS · 1/3
The losses continue

A loss of $48.0M against $1.6B in annual sales.

2
THE RISKS · 2/3
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

3
THE RISKS · 3/3
The price sits above analysts’ target

The stock trades 19% above the average analyst price target.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, TBI sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: TBI has solid sales but closed last year at a loss. The road back to profit runs through spending discipline.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film